S. 1041: Affordable Prescriptions for Patients Act

S. 1041 is a federal bill in the 119th Congress. Before this bill, original biologic drug manufacturers could assert a large, unrestricted number of patents in lawsuits to delay competing cheaper versions, known as biosimilars, from entering the market. After this bill takes effect, original… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.